EMPLOYERS MUTUAL CASUALTY COMPANY et al v. CEPHALON, INC.
Case Number:
2:07-cv-04492
Court:
Nature of Suit:
Other Statutes: Other Statutory Actions
Multi Party Litigation:
Class Action
Judge:
Firms
- Cohen Placitella
- Freed Kanner
- Hagens Berman
- Kessler Topaz
- Kirkendall Dwyer
- Lowey Dannenberg
- Morgan Lewis
- Price Waicukauski
- Saltz Mongeluzzi
- Tucker Law Group
Companies
Sectors & Industries:
-
March 24, 2015
Class Cert. Denied In Cephalon Painkiller Marketing Suit
A Pennsylvania federal judge on Monday refused to certify a proposed class action accusing drugmaker Cephalon Inc. of unjustly enriching itself by marketing a painkiller for off-label uses, ruling the plaintiffs failed to show that a class action was the best way to resolve their claims.
-
July 24, 2013
Drug Buyers Urge Class Cert. In Cephalon Off-Label Use Suit
Two entities that pay for employees' prescription drugs on Wednesday asked a Pennsylvania federal judge to certify a class of other purchasers in a suit alleging that drug manufacturer Cephalon Inc. illegally pushed off-label uses for its painkiller Actiq.
-
October 30, 2012
Cephalon Faces Class Cert. Bid In Actiq Marketing Row
Two companies that chip in for employees' prescription drugs sought class certification last week in a Pennsylvania suit against Cephalon over off-label marketing for the painkiller Actiq, saying the fact that potentially hundreds of companies had to pay for workers' prescriptions made the case suitable for class treatment.
-
March 28, 2011
Cephalon Loses Bid For Quick Win In Marketing Suit
Cephalon Inc. lost a summary judgment bid Wednesday in a Pennsylvania class action claiming the company marketed the cancer pain management drug Actiq for off-label uses and caused third-party payors to pay hundreds of millions of dollars more for prescriptions.